About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT05363189

Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)

Women who have their breast reconstructed with autologous tissue seem to be more satisfied with their breast. However, autologous breast reconstruction entails a bigger operation, and the usage of mor...

Lead sponsor: Vastra Gotaland Region•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Emma Hansson, MD, PhD

CONTACT

0046313421000 emma.em.hansson@vgregion.se

Sponsors

Lead Sponsor

Vastra Gotaland Region

Age

18 - 100 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Operated or will be operated with a DIEP flap in the department
•\>18 years of age

Exclusion Criteria

•Inability to leave informed consent
•Inability to understand and speak Swedish (for the questionnaire)

Related studies

Exercise in Metastatic Breast Cancer: EMBody

NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

NCT03137095 · Cancer Related Cognitive Difficulties, Breast Cancer Female

RECRUITINGPhase 3

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374 · Triple-Negative Breast Cancer

RECRUITINGPhase 3

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

NCT04852887 · Stage I Breast Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 3, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment380

Start dateMay 2022

Last updatedJul 3, 2025

Condition

Breast Reconstruction Breast Cancer

Locations shown

Sahlgrenska university hospital

Gothenburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions